Expanding Liver Transplant Immunosuppression Minimization Via Everolimus

NCT06280950 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

340

Enrollment

NIH

Sponsor class

Conditions

Liver Transplant

Interventions

DRUG: Everolimus
DRUG: Tacrolimus (continued reduction)
DRUG: Tacrolimus (maintain 50% reduction)
DRUG: Everolimus

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)